Avara Pharmaceutical Services has signed an agreement to buy Pfizer’s Liscate, Italy sterile manufacturing facility. “This acquisition is an important component of our strategic plan and expands our services by adding sterile processing capability, which is in very high demand,” said Timothy Tyson, chairman and chief executive officer, Avara. Avara provides both API formulation and manufacturing, along with secondary formulation, manufacturing and packaging of small molecule dr...